Results 211 to 220 of about 553,451 (313)
An Exploratory Study of Honey Consumption Preferences: Insights from a Multi-Model Approach in Kosovo. [PDF]
Hasani A +4 more
europepmc +1 more source
Aims Atypical colitis (presenting reverse gradient colitis, backwash ileitis or rectal sparing) is associated with primary sclerosing cholangitis–ulcerative colitis (PSC). Oral vancomycin has been used to manage paediatric atypical colitis with/without confirmed PSC. Different preparations had shown different efficacy.
Laura Räisänen +4 more
wiley +1 more source
Food Label Readability and Consumption Frequency: Isolating Content-Specific Effects via a Non-Equivalent Dependent Variable Design. [PDF]
Avalos C, Shryane N, Wang Y.
europepmc +1 more source
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun +4 more
wiley +1 more source
Exploring the determinants of online purchase intention for aging-friendly products: evidence from senior consumers in urban Chinese context. [PDF]
Yang L, Xie R, Zhao X, Zheng G, She S.
europepmc +1 more source
Aims To translate a PBPK model developed for the direct oral anticoagulant, dabigatran etexilate, the prodrug of dabigatran, based on data obtained from healthy men to healthy non‐pregnant, pregnant and post‐partum women. To evaluate safety and efficacy of dabigatran etexilate in post‐partum women using simulations and design a future clinical study to
Kayode Ogungbenro +3 more
wiley +1 more source
Aggregate Consumer Exposure and Risk Assessment in the EU-A Case Study. [PDF]
Oltmanns J, Scheibelein C, Grimm FA.
europepmc +1 more source
Effects of Renal and Hepatic Impairment on the Pharmacokinetics of Zilurgisertib
Aim Small‐molecule activin receptor‐like kinase‐2 inhibitor zilurgisertib (INCB000928) is under investigation in a pivotal trial for the treatment of fibrodysplasia ossificans progressiva (FOP), an ultrarare genetic condition. This analysis assessed effects of renal and hepatic impairment on zilurgisertib pharmacokinetics.
Yan‐ou Yang +5 more
wiley +1 more source
Sociodemographic, lifestyle, and dietary characteristics among artificially sweetened beverages consumers in Korea. [PDF]
Kim BH, Shim JE, Song S.
europepmc +1 more source

